Brian V Geisbrecht

9PUBLICATIONS
56CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Biologically active moleculesProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 11, 2026
Bacterial targeting of the neutrophil inhibitory receptor LILRB3 to evade antibody immunity.

|Apr 27, 2026
Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer.

|Nov 22, 2025
The C-terminal domain of Staphylococcus aureus Efb recruits FHR-2 to C3b, synergistically inhibiting the terminal complement pathway.

Huiquan Duan, Elod Kortvely, Jean-Luc Mary

|Oct 21, 2024
The Inhibitory Effects of a Factor B-Binding DNA Aptamer Family Supersede the Gain of Function of Factor B Variants Associated with Atypical Hemolytic Uremic Syndrome.

Huiquan Duan, Ying Zhang, Matthew R Otis

|Dec 27, 2023
Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl)Pyridine-3-Carboximidamide and Chemical Analogs.

Xin Xu, Timothy J Herdendorf, Huiquan Duan

|Nov 30, 2023
New Insights into the Complement Receptor of the Ig Superfamily Obtained from Structural and Functional Studies on Two Mutants.

Huiquan Duan, Troy G Abram, Ana Rita Cruz

Pageof 2

Frequent Collaborators

4 joint publications

Huiquan Duan

2 joint publications

Stefanie M Hauck

2 joint publications

Ying Zhang

2 joint publications

Xin Xu